Home Cart Sign in  
Chemical Structure| 18085-97-7 Chemical Structure| 18085-97-7

Structure of Jaceosidin
CAS No.: 18085-97-7

Chemical Structure| 18085-97-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Jaceosidin, a methylated trihydroxyflavone, can induce apoptosis in cancer cells via activating Bax and also could block signaling pathways related to inflammation. It is first isolated from the Compositae family.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Jaceosidin

CAS No. :18085-97-7
Formula : C17H14O7
M.W : 330.29
SMILES Code : COC1=C(O)C=CC(=C1)C1=CC(=O)C2=C(O)C(OC)=C(O)C=C2O1
MDL No. :MFCD01081948
InChI Key :GLAAQZFBFGEBPS-UHFFFAOYSA-N
Pubchem ID :5379096

Safety of Jaceosidin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
12 types of gastric cancer cells (including AGS, KATO-3, etc.) 20, 40, 60, 80, 100 μM 6, 12, 18, 24, 30 hours JAC showed killing effects on various GC cells with IC50 values ranging from 38.65 to 90.46 μM Redox Rep. 2024 Dec;29(1):2313366
GES-1 normal gastric cells 39 μM 3, 6, 12, 24 hours No increase in apoptosis observed Redox Rep. 2024 Dec;29(1):2313366
AGS gastric cancer cells 39 μM 3, 6, 12, 24 hours Induced apoptosis in AGS cells via the mitochondrial pathway by upregulating Cyto-c, Bad, cle-caspase-3, and cle-PARP expressions and downregulating Bcl-2 expression Redox Rep. 2024 Dec;29(1):2313366
mouse articular chondrocytes 10, 20, 40, 80 μmol/L 12 hours To evaluate the inhibitory effect of Jaceosidin on IL-1β-induced expression of MMP3, MMP13, ADAMTS4, and ADAMTS5. Results showed that Jaceosidin decreased the expression of these proteins in a concentration-dependent manner. J Cell Mol Med. 2020 Jul;24(14):8126-8137
H1975 cells 0, 6, 12, 24 μM 12, 24, 36 hours Evaluate the inhibitory effect of Jaceosidin on the migration of H1975 cells, the results showed that Jaceosidin significantly inhibited the migration of H1975 cells. Heliyon. 2023 May 11;9(5):e16158
A549 cells 0, 6, 12, 24 μM 12, 24, 36 hours Evaluate the inhibitory effect of Jaceosidin on the migration of A549 cells, the results showed that Jaceosidin significantly inhibited the migration of A549 cells. Heliyon. 2023 May 11;9(5):e16158
H1975 cells 9.19 ±1.90 μM (IC50) 72 hours Evaluate the inhibitory effect of Jaceosidin on the proliferation of H1975 cells, the results showed that Jaceosidin significantly inhibited the proliferation of H1975 cells. Heliyon. 2023 May 11;9(5):e16158
A549 cells 12.71 ±0.91 μM (IC50) 72 hours Evaluate the inhibitory effect of Jaceosidin on the proliferation of A549 cells, the results showed that Jaceosidin significantly inhibited the proliferation of A549 cells. Heliyon. 2023 May 11;9(5):e16158
oral squamous cell carcinoma YD-8 cells 10-50 μM 24 hours JAC had a minor effect on the survival of YD-8 cells. Am J Cancer Res. 2021 Oct 15;11(10):4919-4930
Osteosarcoma MG63 cells 10-50 μM 24 hours JAC had a minor effect on the survival of MG63 cells. Am J Cancer Res. 2021 Oct 15;11(10):4919-4930
human GBM T98G cells 10-50 μM 24 hours JAC significantly reduced the survival of T98G cells, induced apoptotic cell death, altered morphological and molecular phenotypes, increased DNA fragmentation, activated cleavage of caspase-3 and PARP, and downregulated the expression of survivin and Bcl-2. Am J Cancer Res. 2021 Oct 15;11(10):4919-4930
HaCaT cells 12.5–100 μM 24 hours Jaceosidin at concentrations of 12.5–100 μM did not affect the proliferation of HaCaT normal epithelial keratinocytes, indicating selective cytotoxicity towards cancer cells. Evid Based Complement Alternat Med. 2018 May 13;2018:5765047
Ca9.22 cells 97.5 μM 24 hours Jaceosidin inhibited Ca9.22 cell proliferation with an IC50 of 97.5 μM, causing morphological changes and cell cycle arrest at the sub-G1 phase. Evid Based Complement Alternat Med. 2018 May 13;2018:5765047
HSC-3 cells 82.1 μM 24 hours Jaceosidin inhibited HSC-3 cell proliferation with an IC50 of 82.1 μM, causing morphological changes and cell cycle arrest at the sub-G1 phase. Evid Based Complement Alternat Med. 2018 May 13;2018:5765047

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice DMM-induced osteoarthritis model Oral 50 mg/kg Every other day for 10 weeks To evaluate the protective effect of Jaceosidin on DMM-induced cartilage destruction. Results showed that Jaceosidin significantly inhibited cartilage destruction, reduced OARSI scores, and subchondral bone plate thickness. J Cell Mol Med. 2020 Jul;24(14):8126-8137
Balb/c nude mice A549 cell xenograft model Intraperitoneal injection 25 mg/kg and 50 mg/kg 7 consecutive days Evaluate the inhibitory effect of Jaceosidin on tumor growth in A549 cell xenograft model, the results showed that Jaceosidin significantly inhibited tumor growth. Heliyon. 2023 May 11;9(5):e16158

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.03mL

0.61mL

0.30mL

15.14mL

3.03mL

1.51mL

30.28mL

6.06mL

3.03mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories